The EnVision Project at University medicine Greifswald

Molecular Imaging is one of the fastest growing areas in basic and applied scientific research. It allows completely novel insights into basic cellular processes and thus creates the potential to better understand crucial pathophysiological mechanisms of diseases and to delineate effective diagnostic and therapeutic methods.

The Ernst Moritz Arndt University (EMAUG) set up the Baltic MR Imaging Center in 2004. It employs more than 50 biologists and physicians working on current applications of magnetic resonance imaging in biology and medicine. However it is becoming increasingly clear that in order to comprehend life processes both under normal and pathologic conditions on the basic level, dynamic molecular imaging is required. So far, the infrastructure and expertise of dynamic molecular imaging is underdeveloped in Greifswald. The EMAUG is located in a convergence region, and the paucity of advanced equipment for research, the lack of a critical mass of experienced researchers, a reduced level of experience and knowledge of researchers as well as fewer international collaborations with highly competitive groups put severe limitations on our capacity to attract research funds from EU programs. Therefore the major objective of this proposal is to redress this balance by (1) stimulating the realization of the full research potential of our Medical Faculty by acquisition of high-tech equipment including a two-photon microscope; (2) achievement of a critical mass of skilled researchers by recruitment of eight experienced researchers; (3) improving S&T experience and knowledge of researchers by exchange of know-how and experience with scientific experts from eight Strategic Partners; (4) organization of workshops on molecular imaging; (5) dissemination and promotional activities. With this add-on value, the EMAUG will become a center of excellence in dynamic molecular imaging in Pomerania.





Prof. Hilary Carswell, Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK.


Profs. Christian Cognard and Bruno Constantin, Institut de Physiologie et Biologie Cellulaires, Poitiers, France.


Prof. Rikard Holmdahl, Division of Medical Inflammation Research (MIR), Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.


Prof. Michael Freissmuth, Department of Pharmacology, Center for Biomolecular Medicine and Pharmacology, Medical University Vienna, Austria.


Prof. Stefan Schulte-Merker, Developmental and Stem Cell Biology Department, Hubrecht Institute-KNAW & University Medical Centre Utrecht, The Netherlands.


Prof. Carl-Philipp Heisenberg, Institute of Science and Technology Austria (IST Austria) at Klosterneuburg, Austria.


Prof. Peter Hegyi, Department of Internal Medicine at the University of Szeged, Hungary.


Prof. Marc A.M.J. van Zandvoort, Department of Biomedical Engineering, Cardiovascular Research Institute Maastricht (CARIM), The Netherlands.


  • Clinic of Neurology-leading role
  • Clinic of Internal Medicine A-Gastroenterology
  • Clinic of Internal Medicine B-Cardiology
  • Institute of Anatomy and Cell Biology
  • Institute of Human Genetics
  • Institute of Immunology
  • Institute of Pathophysiology
  • Institute of Pharmacology